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ABSTRACT
Differentially methylated regions (DMRs) are stable
epigenetic features within or in proximity to im-
printed genes. We used this feature to identify can-
didate human imprinted loci by quantitative DNA
methylation analysis. We discovered a unique DMR
at the 50-end of FAM50B at 6p25.2. We determined
that sense transcripts originating from the FAM50B
locus are expressed from the paternal allele in all
human tissues investigated except for ovary, in
which expression is biallelic. Furthermore, an anti-
sense transcript, FAM50B-AS, was identified to be
monoallelically expressed from the paternal allele in
a variety of tissues. Comparative phylogenetic
analysis showed that FAM50B orthologs are
absent in chicken and platypus, but are present
and biallelically expressed in opossum and mouse.
These findings indicate that FAM50B originated in
Therians after divergence from Prototherians via
retrotransposition of a gene on the X chromosome.
Moreover, our data are consistent with acquisition
of imprinting during Eutherian evolution after diver-
gence of Glires from the Euarchonta mammals.
FAM50B expression is deregulated in testicular
germ cell tumors, and loss of imprinting occurs fre-
quently in testicular seminomas, suggesting an im-
portant role for FAM50B in spermatogenesis and
tumorigenesis. These results also underscore the
importance of accounting for parental origin in
understanding the mechanism of 6p25-related
diseases.
INTRODUCTION
Genomic imprinting results in the differential expression
of the two inherited alleles of a gene in a parent-of-origin
speciﬁc manner. Imprinted genes play important roles in
embryonic growth and development as well as in placental
function. Genetic and epigenetic disruption of imprinted
genes are also associated with a wide range of diseases,
including cancer, behavioral disorders and congenital dis-
orders (1,2).
Approximately 60 genes are known to be imprinted in
humans (3,4). Genome-wide methods used to screen for
imprinted genes have relied on the differential abundance
of the maternal and paternal alleles using subtractive hy-
bridization (5,6), detection of differential expression using
marker polymorphisms (7,8) or transcriptome sequencing
(9). Global screens for novel imprinted loci based on dif-
ferential methylation between paternal and maternal
alleles have also been performed, and include the use of
methylation-sensitive representational difference analyses
(10,11) or detection of differentially methylated regions
(DMRs) in the gametes (12). Each of these methods has
resulted in the identiﬁcation of a relatively small number
of novel imprinted genes. Recently, we performed a
genome-wide screen using a bioinformatics approach
that resulted in the prediction of 156 candidate imprinted
genes in humans (13); however, the imprint status of many
of these genes has not yet been experimentally conﬁrmed.
Perhaps the most consistent and experimentally
amenable feature associated with imprinted genes is the
presence of DMRs located adjacent to or within these
genes. Many such DMRs are established in the gametes,
the only time in development when the maternal and
paternal genomes are in distinct cellular compartments.
Methylation is therefore established in a manner reﬂecting
the sex of the parental individual in which the gametes
reside. This methylation pattern is normally maintained
in all somatic tissues throughout life, irrespective of gene
expression levels (14,15). In the study described in this
article, we used quantitative methylation analysis to
search for novel human DMRs associated with the genes
we predicted to be imprinted on chromosome 6p (13).
Imprinted genes have not previously been identiﬁed at
6p, but a parent-of-origin effect in psoriasis is linked to
this region of the genome (16). Loss of heterozygosity
(LOH) at chromosome 6p25 is also reported in a variety
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carcinoma (17–19). Trisomy or monosomy of 6p25
results in a variety of congenital malformations that
include neuronal defects, psychomotor retardation,
craniofacial defects and abnormalities in organogenesis
(20–24). Most of these characteristics are apparent at
birth, indicating important roles of the involved genes in
early development.
Herein, we report the identiﬁcation of a novel DMR in
the 50-region of the FAM50B locus (GenBank accession
no.: NM_012135) at chromosome 6p25.2. FAM50B
originated from a retrotransposon, and encodes for the
protein XAP-5-like (X5L), which is highly expressed
during spermatogenesis (25). We show that FAM50B tran-
scripts are monoallelically expressed from the paternal
allele in a variety of human tissues. Using phylogenetic
comparisons in vertebrates, we found FAM50B to be
absent in chicken and platypus, but present and
biallelically expressed in the opossum and mouse.
Importantly, our results also show that DMR methylation
at the FAM50B locus is signiﬁcantly reduced in testicular
germ cell tumors (TGCTs), frequently resulting in the
dysregulation of FAM50B expression, including loss of
imprinting in seminomas.
MATERIALS AND METHODS
Tissues
Human conceptus tissues were obtained from the
National Institutes of Health-funded Laboratory of
Human Embryology at the University of Washington,
Seattle. Surgically resected tumor samples and the patho-
logical diagnoses of tumor types were obtained from the
Department of Pathology, Duke University Medical
Center and the National Development and Research
Institutes, Inc (NDRI, New York, NY, USA). Eleven
TGCTs were used in this study, including two embryonal
carcinomas, one seminoma mixed with embryonal carcin-
oma, ﬁve seminomas and three mixed germ cell tumors.
Normal adult human tissues were provided by NDRI and
BioChain Institute (Hayward, CA, USA). All human
tissue specimens were anonymized and used under a
protocol approved by the Duke University Institutional
Review Board.
Gray short-tailed opossum (Monodelphis domestica)
kidney, liver, placenta, brain and embryo samples were
kindly provided by Dr Kathleen Smith (Duke
University, Durham, NC, USA). Mouse liver, brain,
kidney and testis samples were obtained from the F1 gen-
eration of a cross between C57BL/6J and CAST/Ei mouse
strains (Jackson Laboratory, Bar Harbor, ME, USA).
These animal tissues were used under protocols
approved by the Duke University Institutional Animal
Care and Use Committee.
Genomic DNA puriﬁcation and sodium bisulﬁte conversion
Total DNA was isolated from multiple tissues using buffer
ATL, proteinase K and RNase A (Qiagen, Inc., Valencia,
CA, USA) followed by phenol–chloroform extraction and
ethanol precipitation. Bisulﬁte conversion of DNA was
carried out using the Epitect Bisulﬁte Kit (Qiagen Inc.).
Northern blot analysis of FAM50B antisense transcript
(FAM50B-AS)
Northern blot analysis of total RNA from multiple human
tissues was performed using Dig Northern Starter Kit
(Roche Diagnostic, Indianapolis, IN, USA) according to
the manufacturer’s protocol. Two different probes to the
antisense transcript were made using two primer pairs
(FAM-18F/18R; FAM19-F/18R) respectively by PCR.
T7 promoters in the primers FAM-18R and FAM19-R
were used to generate DIG-labeled RNA complementary
to FAM50B-AS by in vitro transcription. Total RNA was
isolated from multiple human conceptus tissues using
RNA-Stat 60 as recommended by the manufacturer
(Tel-Test, Inc., Friendswood, TX, USA). Adult human
total RNA was provided by BioChain Institute.
50- and 30-rapid ampliﬁcations of cDNA ends
RNAs from human conceptus brain and adult testis were
analyzed to locate the 50- and 30-termini of the
FAM50B-AS using the 50/30-rapid ampliﬁcations of
cDNA ends (RACE) kit according to the manufacturer’s
suggested protocol (second generation, Roche Diagno-
stics). For 50-RACE, ﬁrst-strand cDNA was generated
using primer FAM-12F and puriﬁed using the Roche
Diagnostics PCR Product Puriﬁcation kit (Roche
Diagnostics). The 50-end of the puriﬁed cDNA was
further modiﬁed by a tailing reaction. The tailed cDNA
was ampliﬁed using two primers: oligo dT-anchor primer
and FAM-13F. The DNA was re-ampliﬁed with a set of
nested primers including the PCR anchor primer and
FAM-14F (Supplementary Table S1).
For 30-RACE of FAM50B-AS RNA, ﬁrst-strand cDNA
was generated using the oligo dT-anchor primer. The
reverse-transcribed cDNA was ampliﬁed using
semi-nested PCR: the ﬁrst round with the PCR anchor
primer and FAM-14R, the second round with the same
PCR anchor primer and FAM-15R (Supplementary
Table S1). For all specimens, control reactions were per-
formed using cDNA prepared in the absence of primers to
eliminate the possibility of genomic DNA and RNA con-
tamination. These PCR products were then sequenced on
an ABI 3730 DNA sequencer (Applied Biosystems, Foster
City, CA, USA).
Quantitative methylation analysis
Quantitative methylation analysis of DNA in the
FAM50B promoter was performed using MassARRAY
EpiTYPER assays (Sequenom, San Diego, CA, USA).
Primers for human FAM50B (Supplementary Table S1,
FAM-1F/1R to FAM-6F/6R) were designed using
Epidesigner (Sequenom; http://www.epidesigner.com) to
cover the CG-rich regions with amplicons in a target
range of 400–600bp. Each reverse primer was designed
to contain a T7 promoter sequence tag (50-CAG TAA
TAC GAC TCA CTA TAG GGA GAA GGC T-30)
for in vitro transcription, and each forward primer
incorporated a 10-mer tag (50-AGG AAG AGA G-30)t o
Nucleic Acids Research, 2011,Vol.39, No. 13 5389balance the primer annealing temperature with that of the
primer containing the T7 tag. Polymerase chain reaction
ampliﬁcation was performed using HotStarTaq (Qiagen,
Inc.) with the following parameters: polymerase activation
at 95 C for 5min, followed by denaturation at 94 C for
20s, annealing at 60 C for 25s and extension at 72 C for
1min for a total of 40 cycles, with a ﬁnal incubation at
72 C for 5min. After dephosphorylation of unincorpor-
ated dNTPs, the processed PCR products were used in
in vitro transcription reactions (T-cleavage assay) accord-
ing to the manufacturer’s standard protocol (Sequenom).
The transcription products were conditioned to remove
bilvalent cation adducts by dilution with 20mlH 2O
and addition of 6mg of Clean Resin (Sequenom). The
samples were then spotted on a 384-pad Spectro-
CHIP (Sequenom) using a MassARRAY Nanodispenser
(Samsung, Irvine, CA, USA), followed by spectral acqui-
sition on a MassARRAY analyzer compact MALDI-TOF
MS (Sequenom). Fragments containing CpG sites were
analyzed with EpiTyper software (Sequenom) to
generate quantitative methylation fractions at these sites.
The MassARRAY analysis was repeated three times for
each sample and the results were averaged.
Bisulﬁte sequencing of cloned alleles
Genotyping of rs2239713 in the FAM50B promoter region
was carried out to allow for allele-speciﬁc determination
of methylation status. PCR was performed with primers
FAM-7F and FAM-7R (Supplementary Table S1),
followed by BigDye sequencing (Applied Biosystems) on
an ABI 3730 DNA sequencer (Applied Biosystems). The
sense DNA sequence was ampliﬁed from bisulﬁte con-
verted genomic DNA from conceptus tissues using
primers FAM-2F and FAM-4R. The antisense DNA
sequence of heterozygous individuals was ampliﬁed from
bisulﬁte converted genomic DNA from conceptus tissues
and sperm specimens using the following primers:
FAM-8F and FAM-8R. PCR products were directly
ligated into the PCR 2.1 vector using the TOPO TA
Cloning Kit (Invitrogen). Clones for each specimen were
directly sequenced using an ABI BigDye Terminator 3.1
Cycle Sequencing Kit (Applied Biosystems) on an ABI
3730 DNA sequencer (Applied Biosystems).
Genotyping and imprinting expression analyses in
human tissues
Each individual was genotyped for polymorphism
rs6597007 in FAM50B by sequencing genomic DNA.
Genotyping was carried out by PCR with primers
FAM-9F and FAM-9R, followed by BigDye sequencing
(Applied Biosystems) on an ABI 3730 DNA sequencer
(Applied Biosystems). RNA from heterozygous individ-
uals was analyzed to determine whether expression
was monoallelic or biallelic. Total RNA was isolated
from multiple human tissues using RNA-Stat 60 as
recommended by the manufacturer (Tel-Test, Inc.,
Friendswood, TX, USA). First-strand cDNA was syn-
thesized from Dnase I-treated RNA using Superscript II
(Invitrogen), as recommended by the manufacturer using
gene-speciﬁc primer FAM-10R. PCR was performed for
40 cycles with primers FAM-9F and FAM-9R. For all
specimens, control reactions were performed using
cDNA prepared in the absence of reverse transcriptase
to eliminate the possibility of genomic DNA contamin-
ation. The PCR products were gel-extracted (GenElute,
Sigma Chemical Co, St Louis, MO, USA) and directly
sequenced on an ABI 3730 DNA sequencer (Applied
Biosystems).
Allele-speciﬁc expression of FAM50B and FAM50B-AS
transcripts
Strand-speciﬁc RT–PCR was performed to distinguish
between FAM50B and FAM50B-AS for allele-speciﬁc ex-
pression using SNP rs6597007. First strand cDNA was
generated from Dnase I-treated RNA from human
tissues using the oligo dT-anchor primer and the
30-RACE kit as described above. For detection of
FAM50B transcripts, PCR was performed using primer
FAM-9F and the PCR anchor primer. For detection of
FAM50B-AS, PCR was ﬁrst performed using primer
FAM-14R and the PCR anchor primer, followed by
nested PCR using primers FAM-15F and FAM-9R.
SNP rs3196512 was used to determine allelic expression
of FAM50B in TGCTs. Genotyping of genomic DNA was
carried out by PCR with primers FAM-11F and
FAM-11R followed by sequencing. Individuals heterozy-
gous for polymorphism rs3196512 were further analyzed
to distinguish between monoallelic and biallelic expres-
sion. First strand cDNA was generated from Dnase
I-treated RNA using the oligo dT-anchor primer as
described above. RT–PCR was performed using primer
FAM-11F and the PCR anchor primer.
For all specimens, control reactions were performed
using cDNA prepared in the absence of primers to elim-
inate the possibility of genomic DNA and non-speciﬁc
RNA contamination. These PCR products were
sequenced directly. Sequences for all primers used are
provided in Supplementary Table S1.
Relative quantitative RT real-time PCR analysis of
FAM50B and FAM50B-AS
Relative quantiﬁcation of both FAM50B and
FAM50B-AS mRNA expression levels was performed on
an ABI PRISM 7900 HT Sequence Detection System
(Applied Biosystems). First-strand cDNA synthesis was
performed with an oligo dT primer on Dnase I-treated
RNA. Real-time reactions were carried out in duplicate
with QuantiFast SYBR Green PCR Master Mix (Qiagen,
Inc.) in a total reaction volume of 20ml, using thermal
conditions recommended by the manufacturer. For detec-
tion of FAM50B transcripts, real-time PCR was per-
formed using primers FAM-16F and FAM-16R. For
detection of FAM50B-AS transcript levels, real-time
PCR was performed using primers FAM-17F and
FAM-17R that anneal to sequence within intron 1 of
FAM50B. Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was used as an endogenous RNA control.
Target and endogenous control ampliﬁcations were
carried out in separate tubes. Results were analyzed
using SDS RQ Manager 1.2 software. Each Ct value
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centage (percent target=2
 Ct 100).
Analysis of opossum and mouse FAM50B orthologs
Opossum and mouse were screened for genomic DNA
polymorphisms by PCR ampliﬁcation using primer pairs
(Supplementary Table S2, Opossum-1F/1R to -3F/3R;
Mouse-1F/1R to -3F/3R) covering the entire coding
region, followed by sequencing. Total RNA was isolated
from multiple tissues of heterozygotes by homogenization
in RNA-Stat 60 (Tel-Test). First strand cDNA was
synthesized from Dnase I-treated RNA using strand-
speciﬁc primers (Supplementary Table S2, Opossum-RT;
Mouse- RT). cDNA fragments ampliﬁed with primers
Opossum-1F/1R and Mouse-4F/4R were puriﬁed, and
directly sequenced on an ABI 3730 DNA sequencer
(Applied Biosystems). Quantitative DNA methylation
analysis of the FAM50B promoter was performed using
MassARRAY EpiTYPER assays as described above
(primers shown in Supplementary Table S2, Opossum-
4F/4R to -7F/7R and Mouse-5F/5R to -18F/18R).
Statistical analysis
Statistical analysis was carried out using GraphPad Prism
5 software (GraphPad Software, Inc.; La Jolla, CA, USA).
Average CpG methylation and expression between
TGCTs and control tissues were compared by ANOVA
and t-test. Results were considered statistically signiﬁcant
at the 5% signiﬁcance level.
RESULTS
Identiﬁcation of FAM50B antisense transcripts
Many imprinted genes are associated with non-coding
RNAs, often taking the form of antisense transcripts
(26,27). We therefore tested the candidate imprinted
gene FAM50B (13) for the presence of an antisense
transcript using northern blot analysis and RACE. Such
a transcript was detected at this locus, and hereafter
referred to as FAM50B antisense (FAM50B-AS)
(Figure 1A and Supplementary Figure S1). Using RNA
probes speciﬁc to the putative FAM50B-AS sequence, an
appropriately sized band ( 1.7kb) was detected by
northern blotting, with probes to different sequences in
FAM50B-AS detecting the same band (Supplementary
Figure S1). We then identiﬁed the 50-end of
FAM50B-AS at +1506 relative to the FAM50B transla-
tional start codon (Figure 1C). This is also the nucleotide
position where the sense strand mRNA terminates
(GenBank accession no.: NM_012135.1). The results
from 30-RACE demonstrated the terminus of
FAM50B-AS occurs within intron 1 of FAM50B,a t
position  237 relative to the translational start codon
for FAM50B. Also, when sequencing the RT–PCR
product of 30-RACE, the polyA sequence is evident
(Figure 1B) in addition to a correctly positioned consensus
AAUAAA motif that has been shown to be essential for
cleavage and polyadenylation (27nt upstream, within the
10–30nt range; underlined, Figure 1B) (28). A CA
dinucleotide motif which deﬁnes the polyadenylation site
for most genes is also present at the polyadenylation site
identiﬁed for the FAM50B-AS. These results conﬁrm the
presence of FAM50B-AS with length of 1743bp.
Identiﬁcation of a FAM50B-associated DMR
Many imprinted genes are associated with CpG-rich
regions that exhibit differential methylation of the
maternal and paternal alleles. For detection of DMRs,
regions are identiﬁed for which multiple CpG sites show
a methylated to unmethylated ratio of  1:1, a pattern
consistent with DNA methylated on only one chromo-
some. To identify potential DMRs, we used the
Sequenom MassARRAY Epityper (Sequenom) for quan-
titative DNA methylation analysis on bisulﬁte treated
DNA. Validation tests on previously identiﬁed DMRs of
known imprinted genes (PEG3, NAP1L5 and MEG3),
Figure 1. Genomic map of human FAM50B locus. (A) FAM50B-AS
RACE-PCR showing a 211bp product of 50-RACE and an 823bp
product of 30-RACE. M, 100bp DNA ladder. N, control reactions
were performed using cDNA prepared in the absence of primers to
eliminate the possibility of genomic DNA and RNA contamination.
(B) Sequencing of 30-RACE-PCR demonstrates the polyA sequence
and AAUAAA motif (underlined) of FAM50B-AS. (C) The FAM50B
locus spans 2kb of genomic sequence at chromosome 6p25 and consists
of two exons (E1 and E2). Horizontal arrows indicate the sense
(FAM50B) and antisense (FAM50B-AS) transcripts of the gene.
FAM50B-AS originates at the 30-end of FAM50B and terminates
within FAM50B intron 1. The black horizontal line indicates the
position of the DMR. Vertical arrows designate positions of SNPs
rs2239713 (C/T), rs6597007 (G/C), rs3196512 (G/C) and the transla-
tional start codon ATG. The position and direction of primers used for
RACE is indicated by horizontal arrowheads. Primer sequences are
provided in Supplementary Table S1.
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lished data).
We then searched genomic regions 10-kb upstream and
downstream of the candidate imprinted gene FAM50B for
GC rich regions (G+C >40%). We identiﬁed a CpG
island spanning the FAM50B promoter and most of the
gene ( 1353 to +1066 relative to the translational start
codon; Chr6: 3848692-3851100, Version February 2009:
GRCh37/hg19; Figure 1B). We quantiﬁed methylation at
the 166 CpG sites within this region in human conceptus
liver (n=3) and brain (n=3). The core region, from the
12th CpG to 110th CpG ( 884bp to +415bp relative
to the translational start codon), was 30% to 60%
methylated in these tissues, whereas the CpG sites in the
50- and 30-boundary regions were more highly methylated
(Figure 2A). These ﬁndings indicate the existence of a
candidate DMR in the core region.
The average methylation in brain, liver and kidney con-
ceptus tissues (gestational ages 81 and 110 days) did not
signiﬁcantly vary for the region from the 12th to 110th
CpG (P=0.12, n=2, ANOVA) (Figure 2B). We also
determined the degree of methylation for this region in
ejaculated spermatozoa (n=2) and found that it was
strikingly hypomethylated in comparison to the somatic
tissues analyzed (Figure 2B). These ﬁndings indicate that
the methylation observed in this region is either derived
from the oocyte, or is established post-fertilization.
To determine if the DNA methylation present in this
region is allele-speciﬁc, we performed bisulﬁte sequencing
of individual cloned alleles from human conceptus liver
(n=2). These sequences showed that CpG sites in this
region for any cloned allele were either completely
methylated or unmethylated (Figure 3A). These ﬁndings
are consistent with this region comprising a DMR of
 740bp that is likely involved in regulating imprinting
at the FAM50B locus. We also used the single nucleotide
polymorphism rs2239713, which is located between CpG
sites 20 and 21, to distinguish between the parental alleles.
On the sense strand, SNP rs2239713 is a C/T polymorph-
ism that is indistinguishable following bisulﬁte conversion,
so we instead designed primers to analyze the complemen-
tary DNA strand, where the polymorphism is present as a
G or A. Analysis of bisulﬁte-modiﬁed DNA from three
individual conceptus liver tissues of individuals heterozy-
gous for this SNP who have homozygous G/G mothers
showed that methylation is allele speciﬁc, with the mater-
nally derived G allele fully methylated and the paternally
derived A allele fully unmethylated (Figure 3B). Bisulﬁte
sequencing of cloned alleles of mature sperm DNA (n=2)
showed a complete lack of methylation in this region
(Figure 3C), consistent with the previously described
quantitative analysis. These results conﬁrm the presence
of a DMR with maternal DNA methylation at the
FAM50B locus.
Imprinting and expression analysis of the FAM50B locus
in human tissues
To determine if transcripts associated with the FAM50B
locus are monoallelically expressed during early develop-
ment, RT–PCR was performed followed by nucleotide
sequencing of the cDNA in a panel of conceptus tissues
from multiple individuals with gestational ages ranging
from 81 to 113 days. We analyzed a 206bp region con-
taining a single nucleotide polymorphism (rs6597007)
located in exon 2. For human conceptuses showing het-
erozygosity at the polymorphic site, monoallelic expres-
sion of FAM50B was observed in nearly all fetal tissues
analyzed including brain (n=5), liver (n=5), placenta
(n=6), adrenal gland (n=2), kidney (n=1), heart
(n=1) and testis (n=2), while expression was biallelic
in the ovary (n=1) (Figure 4). Furthermore, RT–PCR
followed by nucleotide sequencing of cDNA from adult
testis (n=1) and liver (n=1) from individuals heterozy-
gous for SNP rs6597007 demonstrated that FAM50B
monoallelic expression was maintained in adulthood
(Supplementary Figure S2A).
Matched maternal decidual tissues of informative
conceptuses were genotyped to determine the parental
origin of the expressed FAM50B allele in humans. DNA
Figure 2. CpG methylation status at the FAM50B locus. (A) The
percent methylation of CpG sites 1–166 was quantiﬁed by Sequenom
MassARRAY using DNA from conceptus liver (blue line, n=3) and
brain (red line, n=3). CpG site numbers correspond to the positions
within the GC rich region ( 1353 to +1066 relative to the FAM50B
translational start codon). Arrow indicates the position of the transla-
tional start codon. The location of a DMR is shown by a horizontal
line. (B) Average methylation of CpG sites (12 to 110) does not vary
signiﬁcantly for conceptus tissues from the three germ layers and from
different gestational ages, while sperm shows low levels of methylation
at this locus. B, brain; L, liver; K, kidney; P, placenta; S, sperm; B1, L1
and K1—gestational age of 81 days; B2, L2 and K2—gestational age of
110 days.
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site rs6597007 (G/C) was homozygous C/C for this SNP
(Supplementary Figure S2B). Transcripts in the conceptus
were derived only from the allele containing G at this SNP
position, indicating paternal expression. Identical results
for parental allele-speciﬁc expression were obtained for
three additional matched sets of decidua and conceptus
tissues, demonstrating that only the paternally inherited
allele was expressed.
To determine if both the FAM50B and FAM50B-AS
transcripts are monoallelically expressed, we performed
strand-speciﬁc RT-PCR by amplifying the 30-end of
FAM50B and FAM50B-AS containing SNP rs6597007
using 30-RACE-derived cDNA (Supplementary
Figure S3A). We demonstrated that the FAM50B sense
and antisense transcripts were both monoallelically ex-
pressed from the same allele in conceptus brain (n=1),
adult liver (n=1) and adult testis (n=1) (Figure 4 and
Supplementary Figures S2 and S3B).
The level of expression of FAM50B and FAM50B-AS in
human tissues was determined by relative quantitative
RT–PCR using cDNA derived from a panel of conceptus
and adult tissues (n=2). FAM50B exhibits the highest
expression in pre- and post-natal testis tissue, while
FAM50B-AS expression is highest in conceptus testis
and brain (Supplementary Figure S4A and S4B).
Analysis of genes neighboring FAM50B in human tissues
Imprinted genes are often present as gene clusters in the
genome. We therefore determined if genes neighboring
FAM50B also exhibit imprinted expression. In the
human genome, there are six genes in a 200kb region
centered around FAM50B. The three pseudogenes,
RPS25P7, TDGF4 and LOC728344 are not transcribed,
and there are no annotated SNPs useable for allele-
speciﬁc expression analysis of LOC100289494 and
LOC100289591. The remaining gene, C6orf145, was
analyzed for allele-speciﬁc expression, and we found that
both parental alleles were expressed at approximately
equivalent levels from all conceptus tissues analyzed,
including brain (n=3), heart (n=1), kidney (n=2),
muscle (n=2), lung (n=1) and placenta (n=5)
(Supplementary Figure S5, SNP rs226959) These
ﬁndings cannot, however, exclude the possibility that
C6orf145 is imprinted in a highly tissue- and/or develop-
mental stage-speciﬁc manner.
Evolutionary analysis of FAM50B
FAM50B, also known as XAP-5 like gene (X5L), encodes
a 325 amino acid (AA) protein and arose from the
X-linked XAP-5 gene, most likely by retrotransposition
(25). XAP-5 is a conserved protein found in a wide
range of eukaryotes ranging from the roundworm
(Caenorhabditis elegans) to the human. Amino acid align-
ment of XAP-5 and X5L demonstrates that they are 77%
identical in the human.
To determine the timing of the retrotransposition event
responsible for creating the FAM50B locus during verte-
brate evolution, we compared the region encompassing
FAM50B in human and mouse (Eutherian), opossum
(Metatherian), platypus (Prototherian) and chicken
(Aves) using the UCSC and Ensembl genome browsers
(http://genome.ucsc.edu and http://www.ensembl.org/,
respectively). In the mouse, FAM50B is near C6orf145
Figure 3. Allele-speciﬁc methylation at the FAM50B locus. (A) Clones obtained from bisulﬁte-treated conceptus liver DNA are either predominantly
methylated or unmethylated from the 18th CpG site to the 66th CpG site. (B) Clones obtained from bisulﬁte-treated conceptus liver DNA,
representing one of three individuals heterozygous for SNP rs2239713 (arrow), while their matched maternal deciduae are homozygous G/G for
the SNP sites. The allele-speciﬁc distribution of methylation with respect to the G/A polymorphism demonstrates that the maternally-derived allelei s
methylated while the paternally derived allele is unmethylated. (C) Clones obtained from bisulﬁte-treated mature sperm DNA are completely
unmethylated. CpG sites are represented by circles. Unﬁlled circle, unmethylated CpG site; ﬁlled circle, methylated CpG site.
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encodes a 334 AA protein with 83% sequence similarity
to the human ortholog. BLAST analysis of the platypus
and opossum genomes (http://www.ncbi.nlm.nih.gov/
Genomes) showed that the opossum, but not the
platypus, contains a gene orthologous to FAM50B.
Unlike mouse and human, the opossum FAM50B
ortholog is not located between SLC22A23 and PRPF4B,
but rather resides 78 Mb from the 30-end of SLC22A23.
The opossum FAM50B gene also has an intronless open
reading frame, and encodes a 338 AA protein (Gene ID:
LOC100027108; GenBank accession no.: XM_001370796)
with 76% similarity to the human ortholog. Interestingly,
both FAM50B and C6orf145 are absent in the chicken
genome. These ﬁndings are consistent with FAM50B
having undergone retrotransposition from the X chromo-
some source gene after Therians split from Prototherians.
As in the human and mouse, FAM50B is located
between C6orf145 and PRPF4B (SuperContig Scaffold54
from Ensembl genome browser) in the African elephant
(Loxodonta africana), a member of the most ancestral pla-
cental super order, Afrotheria. Thus, FAM50B appears to
have integrated into the genomic region between C6orf145
and PRPF4B after the divergence of marsupials from an-
cestral Eutherian mammals.
We determined that transcripts from the opossum
FAM50B ortholog have high levels of expression in
kidney, liver, embryo and placenta, but expression was
not detected in the brain (Supplementary Figure S6A).
Transcripts of the mouse FAM50B ortholog were ex-
pressed in liver, kidney, brain and testes (Supplementary
Figure S6B). Nevertheless, expression of FAM50B in the
opossum (Figure 6A) and mouse (Figure 6C) was biallelic
in all tissues investigated. We did not test for the presence
Figure 4. Imprinting analysis of human FAM50B. Genomic DNA
from human conceptuses (A and B) is heterozygous for polymorphism
rs6597007 (G/C). Sequencing of cDNA demonstrates monoallelic ex-
pression of FAM50B transcripts in multiple conceptus tissues, including
brain, liver, placenta, adrenal gland, kidney, heart and testis. In
contrast, FAM50B expression is biallelic in fetal ovary. The position
of SNP rs6597007 used to determine allelic expression is indicated by
the arrows.
Figure 5. Phylogenetic comparison of the genomic structure of
FAM50B and ﬂanking genes. FAM50B is ﬂanked by C6orf145 and
PRPF4B in human (chromosome 6) and mouse (chromosome 13),
but is 78 Mb upstream from the SLC22A23 ortholog in the opossum
(chromosome 3). FAM50B orthologs are not present in the platypus
(UltraContig Ultra 352) and chicken genomes (chromosome 2).
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Moreover, CpG methylation of the genomic region
orthologous to the DMR in the human is comparatively
hypomethylated in the opossum (Figure 6B), and
hypermethylated in the mouse (Figure 6D).
Loss of the methylation imprint in human TGCTs
DMR methylation and allele-speciﬁc expression of
FAM50B in TGCTs was determined to assess the role of
this gene in cancer formation (Figure 7A). Methylation of
the FAM50B DMR was signiﬁcantly reduced (P<0.001,
unpaired t-test) in 10 of 11 TGCTs specimens we
investigated, including two embryonic carcinomas (C1,
5.1±3.9%; C2, 25.8±7.0%) one seminoma mixed with
embryonic carcinoma (SC1, 14.5±5.3%), ﬁve seminomas
(S1, 4.5±2.8%; S2, 8.1±3.8%; S3, 11.7±4.3; S4,
6.2±4.7%; S5, 21.0±7.0%) and mixed germ cell
tumors (M2, 15.7±8.4%; M3, 24.2±6.5%) relative to
that in normal testis (TN, 36.6±7.7%, n=3). DMR
methylation was not signiﬁcantly altered in a mixed
germ cell tumor (M1, 32.4±14.7%; P=0.07).
Quantitative PCR demonstrated that the decreased level
of methylation at the FAM50B DMR in TGCTs was fre-
quently associated with a reduced level of FAM50B and
FAM50B-AS expression (Figure 7B and C). Only
seminoma S3 demonstrated a signiﬁcant increase in ex-
pression of both FAM50B (P<0.001) and FAM50B-AS
(P=0.002) relative to that in normal testis. These ﬁndings
indicate that DMR methylation status alone is insufﬁcient
for regulation of FAM50B and FAM50B-AS transcript
levels in some TGCTs.
To determine if FAM50B imprinting is maintained in
TGCTs, we analyzed tumors heterozygous for SNP
rs3196512 (C/G), which included embryonic carcinomas
C1 and C2, seminomas S2 and S3, and mixed germ cell
tumors M2 and M3, to distinguish the allelic expression
pattern for the FAM50B transcript. We also analyzed the
seminoma mixed with embryonic carcinoma (SC1), which
is heterozygous for SNP rs6597007 (C/G), to determine
the allelic expression pattern for both the sense (S) and
antisense (AS) transcripts (Figure 8). In the embryonic
carcinomas (C1 and C2) and mixed germ cell tumors
(M2 and M3) investigated, monoallelic expression of
FAM50B was maintained (Figure 8A); however, in the
seminomas (S2 and S3) both alleles of FAM50B were ex-
pressed (Figure 8B). Furthermore, both alleles of
FAM50B and FAM50B-AS were expressed in the
seminoma mixed with embryonic carcinoma (SC1)
(Figure 8B). These results indicate that loss of imprinting
at the FAM50B locus is a common event in seminomas.
To determine if the DNA methylation in the DMRs is
involved in regulating imprinting of the FAM50B locus,
Figure 6. Imprinting analysis of FAM50B in the opossum and the
mouse. (A) cDNA sequencing demonstrates biallelic expression of
FAM50B in opossum placenta and liver. Arrows indicate the position
of the SNP used to determine the allelic expression patterns. (B)
Methylation at CpG dinucleotides is <20% for most of the region
that encompasses the opossum FAM50B translational start codon,
from  340 to 972bp. Blue line, DNA from liver; red line, DNA
from kidney. Arrow indicates the position of the translational start
codon. (C) FAM50B cDNA sequencing demonstrates biallelic
expression of the FAM50B in mouse brain and testis. Arrows
indicate the position of the SNP used to determine the allelic expression
patterns. (D) Methylation is >60% at most CpG sites in proximity to
the translational start codon of murine FAM50B (from  8800 to
1120bp relative to translational start codon). Arrow indicates the
position of the translational start codon. Blue line, DNA from
kidney; red line, DNA from liver.
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cloned alleles of S2 (Supplementary Figure S7A) and S3
(Supplementary Figure S7B). Our results showed that
allele-speciﬁc methylation was partially lost in S2 and
S3. These results were associated with the loss of im-
printed expression of FAM50B transcripts in seminomas,
indicating that this DMR is required for maintaining the
imprinted status of this gene.
DISCUSSION
In our search for imprinting regulatory regions on
chromosome 6p, we identiﬁed a novel DMR at the
FAM50B locus, a gene we previously predicted to be
imprinted (13). The unique parent-of-origin-dependent ex-
pression of imprinted genes is in large part regulated by
the methylation status of associated DMRs. There are two
distinct types of DMRs that regulate the expression of
genomically imprinted genes: germline DMRs that are es-
tablished during gametogenesis and somatic DMRs that
are formed post-fertilization, sometimes in a tissue-speciﬁc
Figure 8. Allelic expression of FAM50B in TGCTs. (A) cDNA
sequencing of TGCTs demonstrates maintenance of monoallelic expres-
sion of the FAM50B transcript in embryonic carcinoma C1 and C2 and
mixed germ cell tumor M2 and M3. (B) cDNA sequencing of TGCTs
demonstrates biallelic expression of the FAM50B transcripts in the
seminomas S2 and S3 and biallelic expression of both FAM50B and
FAM50B-AS in seminoma mixed with embryonic carcinoma SC1. The
SNP rs3196512 (G/C) was used to determine allelic expression of
FAM50B in sample C1, C2, M2, M3, S2 and S3. The SNP rs6597007
(G/C) was used to determine allelic expression of FAM50B and
FAM50B-AS in sample SC1. The position of the SNP used to deter-
mine allelic expression is indicated by the arrows.
Figure 7. Methylation status and gene expression of FAM50B locus in
TGCTs. (A) Percent methylation of the FAM50B DMR in each tumor
and in normal testis controls (n=3). (B) Relative expression levels,
normalized to GAPDH,o fFAM50B transcripts in TGCTs and in
normal testis controls (n=3). (C) Relative expression levels,
normalized to GAPDH, of the FAM50B-AS transcripts in TGCTs
and in normal testis controls (n=3). TGCTs include: embryonic car-
cinoma (C1, C2), seminoma mixed with embryonic carcinoma (SC1),
pure seminoma (S1, S2, S3 and S4, S5), and mixed germ cell tumor
(M1, M2 and M3). Normal testis tissue (TN, n=3) was used for
comparison.
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we performed methylation analysis at the FAM50B locus
in human tissues derived from the three germ layers. These
methylation analyses, combined with those of mature
human spermatozoa, identiﬁed a novel DMR at the
promoter region of FAM50B. The FAM50B DMR
showed uniform differential methylation in embryonic
tissues of different germ layer origin. It was maternally
methylated in conceptus liver and unmethylated in
sperm. Thus, this DMR is either a maternal methylation
imprint mark established in oocytes or it is acquired
post-fertilization. Our results therefore support the use
of the Sequenom MassARRAY as an effective tool for
experimentally identifying novel DMRs of imprinted
genes.
We identiﬁed both sense and antisense transcripts of
FAM50B, and conﬁrmed the imprint status of both,
with each transcript displaying paternal expression in
normal human tissues. Thus, we demonstrated for the
ﬁrst time that FAM50B is an imprinted gene in humans.
The function of the gene products from both FAM50B
and its X-linked resource gene XAP-5 are currently
unknown. However, phylogeny indicates related genes
with XAP5 domains in both Brassica and Arabidopsis,
indicating that the origin of FAM50-related genes
occurred early in the development of eukaryotes. Hints
as to function may come from Arabidopsis XCT (XAP-5
circadian timekeeper), which regulates the circadian clock
in response to light, acting as a global regulator of growth
(30).
XAP-5 contains runs of CG-rich trinucleotide repeats
(CCG) in the 50-untranslated region, and therefore is con-
sidered a candidate disease gene (31); however, this triplet
repeat is not present in FAM50B. We found high expres-
sion of FAM50B in embryonic tissues, indicating an im-
portant role in prenatal development. We also found that
FAM50B is highly expressed in testis, consistent with the
prior observation that X-derived retrogenes are more fre-
quently expressed in spermatocytes than autosomally-
derived retrogenes (32).
A considerable proportion of imprinted genes produce
both sense and antisense transcripts, which was our
impetus for searching for a FAM50B antisense transcript.
Non-coding antisense transcripts are broadly classiﬁed
into large non-coding RNAs and small regulatory
RNAs, acting in cis or in trans, respectively, to repress
the ﬂanking protein-coding imprinted genes (26,27).
FAM50B-AS, together with IGF2AS (IGF2 antisense)
(33), APEG3( PEG3 antisense) (34), SLC22A18AS
(SLC22A18 antisense) (35) and PEG1-AS (PEG1 anti-
sense) (36), may be more suitably classiﬁed into a new
RNA group due to their speciﬁc features. First, all are
paternally expressed from the same allele with their
sense transcripts, which differs from the reciprocal im-
printing pattern of large and small non-coding RNAs
(for example, paternally expressed antisense Air and ma-
ternally expressed sense IGF2R; and maternally expressed
miRNA MiR-431 and paternally expressed sense RTL1).
Second, the length of the antisense transcripts is 1–2.5kb,
much shorter than the large non-coding RNAs (usually
10–100kb), but much longer than the small non-coding
RNAs (<300 bases). The biological functions of these
antisense transcripts, whether involved in regulating the
imprinting of their sense transcripts or in maintaining
normal tissue function, remain elusive. Interestingly, im-
printed FAM50B-AS exhibits the highest level of expres-
sion in fetal brain, indicating that FAM50B-AS is
potentially involved in preserving normal brain function.
Multiple transcribed and functional retrotransposed
genes that originated from X-linked housekeeping genes
have been uncovered in the genomes of mammals (37,38).
The percentage of expressed retrotransposons that origin-
ate from X chromosome genes is higher than those
originating from autosomal chromosomes. Five of these
X-derived retrotransposed genes in mice (i.e. MCTS2,
NAP1L5, U2AF1-RS1, Inpp5f_v2 and Peg12) and three
orthologues in humans (i.e. MCTS2, known as
PSIMCT-1, INPP5F_V2 and NAP1L5) are known to be
imprinted, and all are paternally expressed (39,40). In
contrast, KLF14 retrotransposed from an autosomal
chromosome, and is maternally expressed (41). Of particu-
lar interest is RB1, which is not a retrotransposed gene;
however, the preferential maternal expression of the RB1
transcript and the paternal expression of an alternative
transcript of this gene is linked to a retrotransposed
pseudogene derived from an autosomal chromosome
(42). In the case of RB1, the pseudogene is not transcribed,
but rather acts as a weak promoter for an alternate RB1
transcript, regulated by a DMR in the pseudogene (43).
Clearly, retrotransposed elements play an important role
in parental allele silencing of imprinted genes. It has been
hypothesized that the retrotransposition of X-derived
genes is a mechanism to insure continued activity for es-
sential genes that are otherwise silenced by transient
X-chromosome inactivation during spermatogenesis
(32,44). FAM50B is another example of a maternally
silenced imprinted gene derived from an X-linked gene
by retrotransposition. This adds further support to the
hypothesis that imprinting functions in part as a dosage
compensation mechanism (45). However, unlike other
known retrotransposed imprinted genes, FAM50B is not
located within an intron of a host gene.
Comparison of X-inactivation and retrotransposed
genes between marsupials and eutherians may be highly
informative for understanding the evolution of imprinted
gene silencing, especially with regard to the idea that
retrotransposition of X-linked genes compensates for
X-inactivation during spermatogenesis. The recent discov-
ery of X-chromosome inactivation during spermatogen-
esis in opossum has led to a model for the origins
of X-chromosome silencing for dosage compensation
in females. In female marsupials, it is always the
paternal X chromosome that is silenced. Persistence of
X-inactivation that was originally established during
spermatogenesis might explain this paternal-speciﬁc X
chromosome silencing in females. If this is the ancestral
method of mammalian X-inactivation, then the reactiva-
tion and subsequent random inactivation seen in euther-
ians is a modiﬁcation of the simpler marsupial mechanism,
possibly providing resiliency by not forcing dependency
on one X chromosome (46).
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retrotransposed imprinted genes acquired parent-of origin
expression by investigating their evolution in mammals.
Only a small number of imprinted genes in eutherians
are also monoallelically expressed in marsupials (47),
and none of the known eutherian imprinted genes that
originated from retrotransposition events are imprinted
in marsupials. The imprinting of MCTS2, INPP5F_V2
and NAP1L5 is conserved in the human and mouse,
indicating retrotransposition occurred before radiation
of the human and rodent lineages (42). U2af1-rs1 and
Peg12 are postulated to have been created by retrotran-
sposition during mouse evolution after the divergence of
mice and humans since their orthologs are not present in
the human (48). Phylogenetic comparison of the orthologs
of the FAM50B locus indicates that this gene was
integrated into the opossum genome in a position different
from that in human, mouse and elephant. Although it is
expressed in a variety of opossum tissues, we showed that
FAM50B is not imprinted in the opossum. Furthermore,
FAM50B in the mouse does not contain a DMR in the
promoter region, and it is also not imprinted. Hence im-
printed expression of human FAM50B appears to have
originated from a species-speciﬁc retrotransposition
event that occurred subsequent to the radiation of the
human and rodent lineages. These ﬁndings demonstrate
that the repertoires of imprinted genes vary between
species, which is consistent with previous reports
indicating that imprinted genes did not arise at a single
point during evolution (49).
To obtain insight into the importance of FAM50B in
normal spermatogenesis, we analyzed its methylation
proﬁle and expression pattern in seminomatous and
non-seminomatous TGCTs. TGCTs have a pluripotent
nature and display histology reﬂecting that of primordial
germ cells (PGCs) to embryonal and somatic cell differen-
tiation. Seminomas recapitulate some aspects of sperm-
atogenesis, whereas non-seminomas demonstrate
embryonal and extraembryonal differentiation patterns
(50). Besides histological distinctions, they have
epigenetic differences. Seminomas have widespread
hypomethylation, both in CpG islands and globally,
unlike non-seminomas, which have higher methylation
overall (51). This hypomethylation is a signiﬁcant similar-
ity between seminomas and PGCs, which also have very
low methylation levels. All these similarities distinguish
seminomas from other types of TGCTs, and suggest that
seminomas originate from a more primitive, less
differentiated cell type that may be more prone to
tumorigenesis.
The FAM50B DMR showed hypomethylation in
seminomatous and the majority of non-seminomatous
TGCTs; however, complete loss of imprinted expression
of FAM50B and FAM50B-AS was only observed in
seminomas. Although hypomethylation of the reciprocally
imprinted genes, H19 and IGF2, is also observed in
TGCTs, null expression, monoallelic expression and
biallelic expression of these genes are observed in both
seminomatous and non-seminomatous TGCTs (52,53).
Thus, the methylation status of the DMR for H19 and
IGF2 is not always correlated with their allelic expression.
Similarly, imprinted gene expression at the FAM50B locus
is not always associated with the methylation status of its
DMR in non-seminomatous TGCTs. This indicates that
factors other than methylation may contribute to tran-
scriptional regulation of imprinting of FAM50B in
non-seminomatous TGCTs. In support of this idea, a
recent study suggests that histone methylation may act
as the principal regulator of gene expression in
non-seminomas (54). Determination of histone modiﬁca-
tions at the FAM50B locus may help clarify the mechan-
ism regulating imprinted expression of FAM50B in
non-seminomatous TGCTs. Analysis of copy number
variations in TGCTs has also been extensively studied
(55). A number of chromosomal aberrations have been
observed, but none of them are associated with the
6p25 locus containing FAM50B. Additionally, the
similarities of seminomas to undifferentiated PGCs
suggest that seminomas have reduced epigenetic regula-
tion besides the observed hypomethylation, which would
be consistent with the loss of FAM50B imprinting in
only this tumor type. The high frequency of loss of imprint-
ing of FAM50B and FAM50B-AS in the genesis of
seminomas also indicates that imprinted expression of
this gene needs to be tightly regulated during normal
spermatogenesis.
Both segmental duplications and deletions at 6p25 have
been associated with diseases and developmental disorders
(56–59). Genetic loss or gain sometimes detrimentally
alters expression of biallelically expressed genes. In
contrast, when imprinted genes are present at the
location of copy number variation, gene dosage is
usually altered dramatically, ranging from complete loss
of expression to overexpression. Our ﬁnding that the
FAM50B locus is imprinted stresses the importance of
determining parent-of-origin inheritance patterns, in
order to better understand the pathogenesis of diseases
linked to chromosome location 6p25.
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